Ajax-Loading

Roche Holding AG - Other Operating Expenses

Roche Holding AG's Fiscal Year is From January To December - All Figures are in CHF, Billions.

The item "Other-Operating-Expenses" stands at -2.94 Billion Swiss Francs for the trailing twelve months (TTM) period ending 06/30/2025, the lowest value at least since 12/31/2011, the period currently displayed.'
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -9.56 Billion Swiss Francs compared to the value the year prior.
The 1 year change is -9.56 Billion Swiss Francs.
The 3 year change is -3.08 Billion Swiss Francs.
The 5 year change is -3.49 Billion Swiss Francs.
The 10 year change is -1.77 Billion Swiss Francs.

The Serie's long term average value is 0.297 Billion Swiss Francs. It's latest available value, on 06/30/2025, is -3.23 Billion Swiss Francs lower, compared to it's long term average value.
The Serie's change in Swiss Francs from it's minimum value, on 06/30/2025, to it's latest available value, on 06/30/2025, is +0.0 Billion.
The Serie's change in Swiss Francs from it's maximum value, on 12/31/2023, to it's latest available value, on 06/30/2025, is -12.46 Billion.

Other Operating Expenses for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Other Operating Expenses905,699,262,464.00
LogoJohnson & Johnson - Other Operating Expenses486,508,953,600.00
LogoAbbVie Inc - Other Operating Expenses399,570,305,024.00
LogoAstraZeneca PLC - Other Operating Expenses280,205,508,085.11
LogoNovartis AG - Other Operating Expenses255,096,620,580.91